Is It Possible to Eradicate Carbapenem-Resistant Acinetobacter baumannii (CRAB) from Endemic Hospitals?
Abstract
:1. Introduction
2. Materials and Methods
- The paper was published, but only full articles;
- The paper was an epidemiological and/or outbreak report (both in endemic and in epidemic setting);
- The responsible agent of the outbreak was CRAB;
- The paper included description and assessment of IC measures deployed during the outbreak;
- The paper included incidence and/or prevalence of the CRAB infection/colonization;
- The outcome of the outbreak was described.
- In vitro data;
- All other carbapenemases;
- Only diagnostic data;
- Case reports;
- Reviews;
- Other species than human.
3. Results
3.1. Study Characteristics
3.2. IPC Measures
4. Discussion
5. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- World Health Organization. Prioritization of Pathogens to Guide Discovery, Research, and Development of New Antibiotics for Drug Resistant Bacterial Infections, including Tuberculosis; World Health Organization: Geneva, Switzerland, 2017. Available online: https://www.who.int/publications/i/item/WHO-EMP-IAU-2017.12 (accessed on 16 May 2022).
- Perez, F.; Van Duin, D. Carbapenem-resistant Enterobacteriaceae: A menace to our most vulnerable patients. Clevel. Clin. J. Med. 2013, 80, 225–233. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- European Centre for Disease Prevention and Control. Healthcare-Associated Infections Acquired in Intensive Care Units. In ECDC: Annual Epidemiological Report for 2017; European Centre for Disease Prevention and Control (ECDC): Stockholm, Sweeden, 2019. [Google Scholar]
- Jawad, A.; Seifert, H.; Snelling, A.M.; Heritage, J.; Hawkey, P.M. Survival of Acinetobacter baumannii on Dry Surfaces: Comparison of Outbreak and Sporadic Isolates. J. Clin. Microbiol. 1998, 36, 1938–1941. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Polotto, M.; Casella, T.; Tolentino, F.M.; Mataruco, M.M.; Porto, N.K.M.; Binhardi, M.F.B.; Nogueira, M.C.L. Investigation of carbapenemases and aminoglycoside modifying enzymes of Acinetobacter baumannii isolates recovered from patients admitted to intensive care units in a tertiary-care hospital in Brazil. Rev. Soc. Bras. Med. Trop. 2020, 53, e20190044. [Google Scholar] [CrossRef] [PubMed]
- Meschiari, M.; Kaleci, S.; Orlando, G.; Selmi, S.; Santoro, A.; Bacca, E.; Menozzi, M.; Franceschini, E.; Puzzolante, C.; Bedini, A.; et al. Risk factors for nosocomial rectal colonization with carbapenem-resistant Acinetobacter baumannii in hospital: A matched case–control study. Antimicrob. Resist. Infect. Control 2021, 10, 69. [Google Scholar] [CrossRef]
- Latibeaudiere, R.; Rosa, R.; Laowansiri, P.; Arheart, K.; Namias, N.; Munoz-Price, L.S. Surveillance Cultures Growing Carbapenem-Resistant Acinetobacter baumannii Predict the Development of Clinical Infections: A Retrospective Cohort Study. Clin. Infect. Dis. 2015, 60, 415–422. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Magiorakos, A.P.; Burns, K.; Baño, J.R.; Borg, M.; Daikos, G.; Dumpis, U.; Lucet, J.C.; Moro, M.L.; Tacconelli, E.; Simonsen, G.S.; et al. Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: Guidance from the European Centre for Disease Prevention and Control. Antimicrob. Resist. Infect. Control 2017, 6, 113. [Google Scholar] [CrossRef] [PubMed]
- European Centre for Disease Prevention and Control. ECDC Technical Report: Risk Assessment on the Spread of Carbapenemase-Producing Enterobacteriaceae (CPE) through Patient Transfer between Healthcare Facilities, with Special Emphasis on Cross-Border Transfer; European Centre for Disease Prevention and Control: Stockholm, Sweeden, 2011.
- Lortholary, O.; Fagon, J.-Y.; Hoi, A.B.; Slama, M.A.; Pierre, J.; Giral, P.; Rosenzweig, R.; Gutmann, L.; Safar, M.; Acar, J. Nosocomial Acquisition of Multiresistant Acinetobacter baumannii: Risk Factors and Prognosis. Clin. Infect. Dis. 1995, 20, 790–796. [Google Scholar] [CrossRef]
- Tomczyk, S.; Zanichelli, V.; Grayson, M.L.; Twyman, A.; Abbas, M.; Pires, D.; Allegranzi, B.; Harbarth, S. Control of Carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa in Healthcare Facilities: A Systematic Review and Reanalysis of Quasi-experimental Studies. Clin. Infect. Dis. 2019, 68, 873–884. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tamma, P.D.; Aitken, S.L.; A Bonomo, R.; Mathers, A.J.; van Duin, D.; Clancy, C.J. Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase–Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections. Clin. Infect. Dis. 2021, 74, 2089–2114. [Google Scholar] [CrossRef]
- Russo, A.; Gavaruzzi, F.; Ceccarelli, G.; Borrazzo, C.; Oliva, A.; Alessandri, F.; Magnanimi, E.; Pugliese, F.; Venditti, M. Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit. Infection 2022, 50, 83–92. [Google Scholar] [CrossRef]
- Thoma, R.; Seneghini, M.; Seiffert, S.N.; Vuichard Gysin, D.; Scanferla, G.; Haller, S.; Flury, D.; Boggian, K.; Kleger, G.R.; Filipovic, M.; et al. The challenge of preventing and containing outbreaks of multidrug-resistant organisms and Candida auris during the coronavirus disease 2019 pandemic: Report of a carbapenem-resistant Acinetobacter baumannii outbreak and a systematic review of the literature. Antimicrob. Resist. Infect. Control 2022, 11, 12. [Google Scholar] [CrossRef]
- Rangel, K.; Chagas, T.P.G.; De-Simone, S.G. Acinetobacter baumannii Infections in Times of COVID-19 Pandemic. Pathogens 2021, 10, 1006. [Google Scholar] [CrossRef] [PubMed]
- Lötsch, F.; Albiger, B.; Monnet, D.L.; Struelens, M.J.; Seifert, H.; Kohlenberg, A.; European Antimicrobial Resistance Genes Surveillance Network (EURGen-Net) Carbapenem-Resistant Acinetobacter baumannii Capacity Survey Group. Epidemiological situation, laboratory capacity and preparedness for carbapenem-resistant Acinetobacter baumannii in Europe, 2019. Eurosurveillance 2020, 25, 2001735. [Google Scholar] [CrossRef]
- Baker, M.A.; E Sands, K.; Huang, S.S.; Kleinman, K.; Septimus, E.J.; Varma, N.; Blanchard, J.; E Poland, R.; Coady, M.H.; Yokoe, D.S.; et al. The Impact of Coronavirus Disease 2019 (COVID-19) on Healthcare-Associated Infections. Clin. Infect. Dis. 2021, 74, 1748–1754. [Google Scholar] [CrossRef] [PubMed]
- Weiner-Lastinger, L.; Pattabiraman, V.; Konnor, R.; Patel, P.; Wong, E.; Xu, S.Y.; Smith, B.; Edwards, J.R.; Dudeck, M. The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: A summary of data reported to the National Healthcare Safety Network. Infect. Control Hosp. Epidemiol. 2022, 43, 12–25. [Google Scholar] [CrossRef] [PubMed]
- Perez, S.; Innes, G.K.; Walters, M.; Mehr, J.; Arias, J.; Greeley, R.; Chew, D. Increase in Hospital-Acquired Carbapenem-Resistant Acinetobacter baumannii Infection and Colonization in an Acute Care Hospital during a Surge in COVID-19 Admissions—New Jersey, February–July 2020. MMWR. Morb. Mortal. Wkly. Rep. 2020, 69, 1827–1831. [Google Scholar] [CrossRef]
- Antimicrobial Consumption in the EU/EEA (ESAC-Net)—Annual Epidemiological Report for 2020. Available online: https://www.ecdc.europa.eu/en/antimicrobial-consumption/surveillance-and-disease-data/database (accessed on 18 November 2021).
- Tacconelli, E.; Cataldo, M.A.; Dancer, S.J.; De Angelis, G.; Falcone, M.; Frank, U.; Kahlmeter, G.; Pan, A.; Petrosillo, N.; Rodríguez-Baño, J.; et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin. Microbiol. Infect. 2014, 20 (Suppl. 1), 1–55. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- World Health Organization. Guidelines for the Prevention and Control of Carbapenem-Resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in Health Care Facilities; World Health Organization: Geneva, Switzerland, 2017. Available online: https://apps.who.int/iris/handle/10665/259462 (accessed on 27 May 2022).
- Tacconelli, E.; Buhl, M.; Humphreys, H.; Malek, V.; Presterl, E.; Rodriguez-Baño, J.; Vos, M.C.; Zingg, W.; Mutters, N.T. Analysis of the challenges in implementing guidelines to prevent the spread of multidrug-resistant gram-negatives in Europe. BMJ Open 2019, 9, e027683. [Google Scholar] [CrossRef] [PubMed]
- US Centers for Disease Control and Prevention (CDC). Facility Guidance for Control of Carbapenem-Resistant Enterobacteriaceae (CRE)—November 2015 Update CRE Toolkit; Centers for Disease Control and Prevention: Atlanta, GA, USA, 2015.
- Agency for Healthcare Research and Quality. Carbapenem-Resistant Enterobacteriaceae (CRE) Control and Prevention Toolkit; Content Last Reviewed April 2014; Agency for Healthcare Research and Quality: Rockville, MD, USA, 2014. Available online: https://www.ahrq.gov/hai/patient-safety-resources/cre-toolkit/index.html (accessed on 1 May 2022).
- Cho, O.H.; Bak, M.H.; Baek, E.H.; Park, K.-H.; Kim, S.; Bae, I.G. Successful control of carbapenem-resistant Acinetobacter baumannii in a Korean university hospital: A 6-year perspective. Am. J. Infect. Control 2014, 42, 976–979. [Google Scholar] [CrossRef] [PubMed]
- Munoz-Price, L.S.; Carling, P.; Cleary, T.; Fajardo-Aquino, Y.; DePascale, D.; Jimenez, A.; Hughes, M.; Namias, N.; Pizano, L.; Kett, D.H.; et al. Control of a two-decade endemic situation with carbapenem-resistant Acinetobacter baumannii: Electronic dissemination of a bundle of interventions. Am. J. Infect. Control 2014, 42, 466–471. [Google Scholar] [CrossRef]
- Valencia-Martín, R.; Gonzalez-Galan, V.; Alvarez-Marín, R.; Cazalla-Foncueva, A.M.; Aldabó, T.; Gil-Navarro, M.V.; Alonso-Araujo, I.; Martin, C.; Gordon, R.; García-Nuñez, E.J.; et al. A multimodal intervention program to control a long-term Acinetobacter baumannii endemic in a tertiary care hospital. Antimicrob. Resist. Infect. Control 2019, 8, 199. [Google Scholar] [CrossRef] [PubMed]
- Enfield, K.B.; Huq, N.N.; Gosseling, M.F.; Low, D.J.; Hazen, K.C.; Toney, D.M.; Slitt, G.; Zapata, H.J.; Cox, H.L.; Lewis, J.D.; et al. Control of Simultaneous Outbreaks of Carbapenemase-Producing Enterobacteriaceae and Extensively Drug-ResistantAcinetobacter baumannii Infection in an Intensive Care Unit Using Interventions Promoted in the Centers for Disease Control and Prevention 2012 Carbapenemase-Resistant Enterobacteriaceae Toolkit. Infect. Control Hosp. Epidemiol. 2014, 35, 810–817. [Google Scholar] [CrossRef] [PubMed]
- Karampatakis, T.; Tsergouli, K.; Iosifidis, E.; Antachopoulos, C.; Karapanagiotou, A.; Karyoti, A.; Gritsi-Gerogianni, N.; Tsakris, A.; Roilides, E. Impact of active surveillance and infection control measures on carbapenem-resistant Gram-negative bacterial colonization and infections in intensive care. J. Hosp. Infect. 2018, 99, 396–404. [Google Scholar] [CrossRef] [PubMed]
- Eckardt, P.; Canavan, K.; Guran, R.; George, E.; Miller, N.; Avendano, D.H.; Kim, M.; Himed, K.; Ramirez, K.H.G. Containment of a carbapenem-resistant Acinetobacter baumannii complex outbreak in a COVID-19 intensive care unit. Am. J. Infect. Control 2022, 50, 477–481. [Google Scholar] [CrossRef] [PubMed]
- Chung, Y.K.; Kim, J.S.; Lee, S.S.; Lee, J.A.; Kim, H.S.; Shin, K.-S.; Park, E.Y.; Kang, B.S.; Lee, H.J.; Kang, H.J. Effect of daily chlorhexidine bathing on acquisition of carbapenem-resistant Acinetobacter baumannii (CRAB) in the medical intensive care unit with CRAB endemicity. Am. J. Infect. Control 2015, 43, 1171–1177. [Google Scholar] [CrossRef] [PubMed]
- Meschiari, M.; Lòpez-Lozano, J.M.; Di Pilato, V.; Gimenez-Esparza, C.; Vecchi, E.; Bacca, E.; Orlando, G.; Franceschini, E.; Sarti, M.; Pecorari, M.; et al. A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit. Antimicrob. Resist. Infect. Control 2021, 10, 123. [Google Scholar] [CrossRef]
- Zhao, Y.; Hu, K.; Zhang, J.; Guo, Y.; Fan, X.; Wang, Y.; Mensah, S.D.; Zhang, X. Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in ICU of the eastern Heilongjiang Province, China. BMC Infect. Dis. 2019, 19, 452, Erratum in BMC Infect. Dis. 2019, 19, 621. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ben-Chetrit, E.; Wiener-Well, Y.; Lesho, E.; Kopuit, P.; Broyer, C.; Bier, L.; Assous, M.V.; Benenson, S.; Cohen, M.J.; McGann, P.T.; et al. An intervention to control an ICU outbreak of carbapenem-resistant Acinetobacter baumannii: Long-term impact for the ICU and hospital. Crit. Care 2018, 22, 319. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Metan, G.; Zarakolu, P.; Otlu, B.; Tekin, İ.; Aytaç, H.; Bölek, E.Ç.; Metin, B.C.; Arsava, E.M.; Ünal, S. Emergence of colistin and carbapenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii (CCR-Acb) complex in a neurological intensive care unit followed by successful control of the outbreak. J. Infect. Public Health 2020, 13, 564–570. [Google Scholar] [CrossRef] [PubMed]
- Oldenkamp, R.; Schultsz, C.; Mancini, E.; Cappuccio, A. Filling the gaps in the global prevalence map of clinical antimicrobial resistance. Proc. Natl. Acad. Sci. USA 2021, 118, e2013515118, Erratum in Proc. Natl. Acad. Sci. USA 2021, 118, e2116827118. [Google Scholar] [CrossRef] [PubMed]
- The Center for Disease Dynamics, Economics & Policy. ResistanceMap: [Resistance of Acinetobacter baumannii to Carbapenems]. 2022. Available online: https://resistancemap.cddep.org/AntibioticResistance.php (accessed on 23 May 2022).
- European Centre for Disease Prevention and Control. Carbapenem-Resistant Acinetobacter baumannii Related to Recent Hospitalisation in Ukraine; European Centre for Disease Prevention and Control: Stockholm, Sweden, 2022.
- World Health Organization. Guidelines on Core Components of Infection Prevention and Control Programmes at the National and Acute Health Care Facility Level; World Health Organization: Geneva, Switzerland, 2016. Available online: https://apps.who.int/iris/handle/10665/251730 (accessed on 6 June 2022).
- Association for Professionals in Infection Control and Epidemiology (APIC). Guide to the Elimination of Multidrug-Resistant Acinetobacter baumannii Transmission in Healthcare Settings; Association for Professionals in Infection Control and Epidemiology: Washington, DC, USA, 2010. [Google Scholar]
- World Health Organization. Hand Hygiene Technical Reference Mannual; World Health Organization: Geneva, Switzerland, 2009. Available online: https://apps.who.int/iris/handle/10665/44196 (accessed on 12 June 2022).
- Anderson, D.J.; Chen, L.F.; Weber, D.J.; Moehring, R.W.; Lewis, S.S.; Triplett, P.F.; Blocker, M.; Becherer, P.; Schwab, J.C.; Knelson, L.P.; et al. Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the Benefits of Enhanced Terminal Room Disinfection study): A cluster-randomised, multicentre, crossover study. Lancet 2017, 389, 805–814. [Google Scholar] [CrossRef]
- Anderson, D.J.; Knelson, L.P.; Moehring, R.W.; Lewis, S.S.; Weber, D.J.; Chen, L.F.; Triplett, P.F.; Blocker, M.; Cooney, R.M.; Schwab, J.C.; et al. Implementation Lessons Learned from the Benefits of Enhanced Terminal Room (BETR) Disinfection Study: Process and Perceptions of Enhanced Disinfection with Ultraviolet Disinfection Devices. Infect. Control Hosp. Epidemiol. 2018, 39, 157–163. [Google Scholar] [CrossRef] [PubMed]
- Dancer, S.J.; King, M.F. Systematic review on use, cost and clinical efficacy of automated decontamination devices. Antimicrob. Resist. Infect. Control 2021, 10, 34. [Google Scholar] [CrossRef]
- Fan, C.Y.; Lee, W.T.; Hsu, T.C.; Lee, C.H.; Wang, S.P.; Chen, W.S.; Huang, C.H.; Lee, C.C. Effect of chlorhexidine bathing on colonization or infection with Acinetobacter baumannii: A systematic review and meta-analysis. J. Hosp. Infect. 2019, 103, 284–292. [Google Scholar] [CrossRef] [PubMed]
- Rizk, N.A.; Zahreddine, N.; Haddad, N.; Ahmadieh, R.; Hannun, A.; Bou Harb, S.; Haddad, S.F.; Zeenny, R.M.; Kanj, S.S. The Impact of Antimicrobial Stewardship and Infection Control Interventions on Acinetobacter baumannii Resistance Rates in the ICU of a Tertiary Care Center in Lebanon. Antibiotics 2022, 11, 911. [Google Scholar] [CrossRef]
Study | Country | Type of Study | Setting | Department Involved | ICU y/n | Statistical Method |
---|---|---|---|---|---|---|
Perez et al., 2020 [19] | USA | Outbreak Report | Epidemic | Acute Care Hospital | No | ITS: CRAB_ID decreased |
Cho et al., 2014 [26] | South Korea | Research support, Non-U.S. Gov’T | Endemic | Tertiary Hospital | No | SR: CRAB_ID decreased |
Munoz-Price et al., 2014 [27] | USA | Major Article | Endemic | Major Hospital | Yes | SR: CRAB hospital acquired cases decrease |
Valencia-Martìn et al., 2019 [28] | Spain | Research | Endemic | Intensive care Unit + adult wards | Yes | JP + ITS: SC decreased |
Enfield et al., 2014 [29] | USA | Comparative Study | Epidemic | Intensive care Unit | Yes | ITS: CRAB_ID decreased |
Karampatakis et al., 2018 [30] | Greece | Epidemiological Stuy | Endemic | Intensive care Unit | Yes | ITS: linear trend of CMA for CRAB infections increased |
Eckardt et al., 2022 [31] | USA | Major Article | Epidemic | Intensive care Unit | Yes | ITS: CRAB_ID decreased |
Chung et al., 2015 [32] | South Korea | Research support, Non-U.S. Gov’T | Endemic | Intensive care Unit | Yes | ITS: CRAB_ID decreased |
Meschiari et al., 2020 [33] | Italy | Research | Epidemic | Intensive care Unit | Yes | ITSA: CRAB_ID decreased |
Zhao et al., 2019 [34] | China | Research | Epidemic | Intensive care Unit | Yes | CS: prevalence of CRAB decreased |
Ben-chetrit et al. [35] | Israel | Research | Epidemic | Intensive care Unit | Yes | SR: CRAB_ID decreased |
Metan et al., 2019 [36] | Turkey | Original Article | Epidemic | Neurological Intensive care Unit | Yes | BA: CRAB_ID decreased |
Study | HH Compliance/AHR Consumption | Active Rectal Screening (Targeted/Universal) | Additional Active Screening Strategies | Contact Isolation /Alert Code | Daily Chlorhexidine Baths | Cohorting Staff/patients | Closure/Stop Admissions | Environmental Disinfection | Environmental Cultures | Monitoring of Environmental Cleaning | Genotyping | Antimicrobial Stewardship/Monitoring of Antibiotic Consumption | Training /Education | Outcome |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Perez et al., 2020 [19] | ||||||||||||||
Cho et al., 2014 [26] | ||||||||||||||
Munoz-Price et al., 2014 [27] | ||||||||||||||
Valencia-Martìn et al., 2019 [28] | ||||||||||||||
Enfield et al., 2014 [29] | ||||||||||||||
Karampatakis et al., 2018 [30] | ||||||||||||||
Eckardt et al., 2022 [31] | ||||||||||||||
Chung et al., 2015 [32] | ||||||||||||||
Meschiari et al., 2020 [33] | ||||||||||||||
Zhao et al., 2019 [34] | ||||||||||||||
Ben-chetrit et al. [35] | ||||||||||||||
Metan et al., 2019 [36] | ||||||||||||||
All studies | ||||||||||||||
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Medioli, F.; Bacca, E.; Faltoni, M.; Burastero, G.J.; Volpi, S.; Menozzi, M.; Orlando, G.; Bedini, A.; Franceschini, E.; Mussini, C.; et al. Is It Possible to Eradicate Carbapenem-Resistant Acinetobacter baumannii (CRAB) from Endemic Hospitals? Antibiotics 2022, 11, 1015. https://doi.org/10.3390/antibiotics11081015
Medioli F, Bacca E, Faltoni M, Burastero GJ, Volpi S, Menozzi M, Orlando G, Bedini A, Franceschini E, Mussini C, et al. Is It Possible to Eradicate Carbapenem-Resistant Acinetobacter baumannii (CRAB) from Endemic Hospitals? Antibiotics. 2022; 11(8):1015. https://doi.org/10.3390/antibiotics11081015
Chicago/Turabian StyleMedioli, Filippo, Erica Bacca, Matteo Faltoni, Giulia Jole Burastero, Sara Volpi, Marianna Menozzi, Gabriella Orlando, Andrea Bedini, Erica Franceschini, Cristina Mussini, and et al. 2022. "Is It Possible to Eradicate Carbapenem-Resistant Acinetobacter baumannii (CRAB) from Endemic Hospitals?" Antibiotics 11, no. 8: 1015. https://doi.org/10.3390/antibiotics11081015
APA StyleMedioli, F., Bacca, E., Faltoni, M., Burastero, G. J., Volpi, S., Menozzi, M., Orlando, G., Bedini, A., Franceschini, E., Mussini, C., & Meschiari, M. (2022). Is It Possible to Eradicate Carbapenem-Resistant Acinetobacter baumannii (CRAB) from Endemic Hospitals? Antibiotics, 11(8), 1015. https://doi.org/10.3390/antibiotics11081015